|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 409 12th Street SW |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
|
5. Senate ID# 400578740-12
|
||||||||
|
6. House ID# 412490000
|
TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Erin Mahaffey |
Date | 10/19/2015 12:10:30 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control and Prevention (CDC); Agency for Healthcare Research and Quality (AHRQ).
Comprehensive Sexuality Education (general); International family planning; National Fetal Infant Mortality Review (HRSA); Department of Defense (DOD); Ovarian Cancer Research Program; Health Disparities (HHS); Safe Motherhood (CDC); Preterm Birth Research (NIH); Vital Statistics (CDC); Maternal Morbidity Research (NIH); Maternity Consumer Assessment of Health Care Providers and Systems (AHRQ); Title V Block Grant (HRSA); Title X, Family Planning (HRSA); Reproductive Health; Birth Defects; Medicaid and Medicare; Pregnancy Risk Assessment Monitoring System (CDC); Division of STD Prevention (CDC); National Center for Environmental Health (CDC); National Health Service Corps (HRSA); FY16 Appropriations: Labor-Health and Human Services-Education, Agriculture-Rural Development-Food and Drug Administration, Homeland Security, and Department of Defense; FY16 Budget House, Senate, and Presidential, including the Reconciliation process; H.R. 719, TSA Office of Inspection Accountability Act of 2015 (Continuing Resolution).
17. House(s) of Congress and Federal agencies Check if None
Centers For Disease Control & Prevention (CDC), Office of Management & Budget (OMB), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Agency for Healthcare Research & Quality (AHRQ), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Rachel |
Gandell |
|
|
|
Mary |
Schilling |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Health Insurance Coverage, Genetic Testing (general); Health Disparities (general); Emergency Contraception (general); Health Care Reform Implementation; Drug Dependence (general); HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding (general); Medical Liability Reform (general); Health IT (general); Prematurity (general); Disparities (general); Prevention and Public Health Fund (general); Maternal Mortality (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); Postpartum Depression (general); CMS Provider Penalties (general); Preeclampsia (general); National Health Service Corps (general); Abortion (general); Indian Health (general); Teaching Health Centers (general); Research in Pregnant and Breastfeeding Women (general); H.R. 2866, Healthy MOM Act; CMS Health IT Incentive Program, Meaningful Use Stage 3; H.R. 1974, HEAL for Immigrant Women and Families Act of 2015; S. 466, Quality Care for Moms and Babies Act; S. 1427, Quality Measure Alignment Act of 2015; H.R. 836/S. 884, Health Care Safety Net Enhancement Act; H.R. 3658/S. 84, GEDI Act; H.R. 2603/S. 1475, Saving Lives, Saving Costs Act; Pregnancy Discrimination (general); S. 821, BPA in Food Packaging Right to Know Act; H.R. 1209/S.628 Improving Access to Maternity Care Act; H.R. 1462/S.799, Protecting our Infants Act; H.R. 6, 21st Century Cures Act; Innovation for Healthier Americans; Health Equity and Accountability Act; H.R. 293 Exempt certain transfers of value from reporting requirements under Sunshine Act; H.R. 1375/S. 142, Child Nicotine Poisoning Prevention Act; H.R. 3652/S. 674, 21st Century Womens Health Act; H.R.7/S. 582, No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2015; H.R.36/S. 1553, Pain-Capable Unborn Child Protection Act; H.R. 448/S.217, Women's Health Protection Act of 2015; H.R. 865, Good Samaritan Health Professionals Act of 2015; H.R. 2654/S. 1512, Pregnant Workers Fairness Act; S. 1532, Affordability is Access Act; H.R. 2191/S. 1170, Breast Cancer Research Stamp Reauthorization Act of 2015; H.R. 1925, To award a Congressional Gold Medal to Dr. Ernie Bodai; H.R. 2058, FDA Deeming Authority Clarification Act of 2015; H.R. 3656/S. 2100, Tobacco to 21 Act; H.R. 3441, Accurate Education for Prenatal Screenings Act; H.R. 3339/S. 1926, Protecting Access to Lifesaving Screenings Act; H.R. 3235, Bringing Postpartum Depression Out of the Shadows Act; Shackling During Pregnancy (general); H.R. 3134/S. 764, Defund Planned Parenthood Act; H.R. 3504/S. 1603, Born-Alive Abortion Survivors Protection Act; H.R. 3495, Womens Public Health and Safety Act; H.R. 3539, Reinvigorating Antibiotic and Diagnostic Innovation; H.R. 3539, Reinvigorating Antibiotic and Diagnostic Innovation Act; H.R. 2407, School Milk Nutrition Act of 2015.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Defense - Dept of (DOD), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), White House Office, Executive Office of the President (EOP), Equal Employment Opportunity Commission (EEOC), Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Gandell |
|
|
|
Nevena |
Minor |
|
|
|
Mary |
Schilling |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R.2, Medicare Access and CHIP Reauthorization Act of 2015; H.R. 1190/ S. 141, Protecting Seniors' Access to Medicare Act of 2015; H.R. 2253/S.737, Ensuring Access to Primary Care for Women & Children Act; Medicaid Managed Care; Medicaid (general); Medicare reimbursement (general).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Rachel |
Gandell |
|
|
|
Mary |
Schilling |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
H.R. 742/S. 358, Access to Contraception for Women Service Members and Dependents Act of 2015; H.R. 1735/S. 1376, National Defense Authorization Act for Fiscal Year 2016.
17. House(s) of Congress and Federal agencies Check if None
Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Gandell |
|
|
|
Nevena |
Minor |
|
|
|
Mary |
Schilling |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
S. 699, Frank R. Lautenberg Chemical Safety for the 21st Century Act.
17. House(s) of Congress and Federal agencies Check if None
Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Gandell |
|
|
|
Nevena |
Minor |
|
|
|
Mary |
Schilling |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |